A R Langkilde
Overview
Explore the profile of A R Langkilde including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
98
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Olsson A, Gustavsen S, Langkilde A, Hansen T, Sellebjerg F, Bach Sondergaard H, et al.
Mult Scler Relat Disord
. 2021 Jul;
54:103136.
PMID: 34247104
Background: Tight junction proteins contribute to maintenance of epithelial and endothelial barriers such as the intestinal barrier and the blood brain barrier (BBB). Increased permeability of these barriers has been...
2.
Olsson A, Gustavsen S, Hasselbalch I, Langkilde A, Sellebjerg F, Oturai A, et al.
Mult Scler Relat Disord
. 2020 Sep;
46:102520.
PMID: 32980645
Background: There is a lack of reliable biomarkers predicting disability and disease activity in multiple sclerosis (MS). Recent evidence suggests an involvement of intestinal and pulmonary epithelial barrier function related...
3.
Modvig S, Degn M, Roed H, Sorensen T, Larsson H, Langkilde A, et al.
Mult Scler
. 2015 Feb;
21(14):1761-70.
PMID: 25698172
Background: Cerebrospinal fluid (CSF) biomarkers have been suggested to predict multiple sclerosis (MS) after clinically isolated syndromes, but studies investigating long-term prognosis are needed. Objective: To assess the predictive ability...
4.
Braendstrup P, Langkilde A, Schreiber K, Ravnborg M, Sellebjerg F, Vindelov L
Case Rep Neurol
. 2012 Jun;
4(2):101-6.
PMID: 22740825
Background: Allogeneic hematopoietic cell transplantation (allo-HCT) has been proposed as treatment for multiple sclerosis (MS) and other autoimmune diseases. Aims: To describe the effects of allo-HCT on the course of...
5.
Soelberg Sorensen P, Tscherning T, Mathiesen H, Langkilde A, Ross C, Ravnborg M, et al.
Neurology
. 2006 Nov;
67(9):1681-3.
PMID: 17101906
We measured neutralizing antibodies (NABs) and the in vivo biologic response to interferon-beta on neopterin and beta(2)-microglobulin blood levels. All NAB-negative patients had an in vivo biologic response (full or...
6.
Jensen J, Langkilde A, Frederiksen J, Sellebjerg F
J Neuroimmunol
. 2006 Aug;
179(1-2):163-72.
PMID: 16919783
An increased percentage of blood CD8+ T cells from patients with clinically isolated syndromes (CIS) suggestive of multiple sclerosis (MS) was found to express CD26 and CD69. The percentage of...
7.
Jensen J, Langkilde A, Fenst C, Nicolaisen M, Roed H, Christiansen M, et al.
J Neuroimmunol
. 2004 Mar;
149(1-2):202-9.
PMID: 15020081
We studied CD4 T cell activation in patients with clinically isolated syndromes (CIS) suggesting an initial attack of multiple sclerosis. The percentage of blood CD26+ CD4 T cells was increased...
8.
Langkilde A, Frederiksen J, Rostrup E, Larsson H
Eur J Neurol
. 2002 May;
9(3):277-86.
PMID: 11985636
The volume of cortical activation as detected by functional magnetic resonance imaging (fMRI) in the visual cortex has previously been shown to be reduced following optic neuritis (ON). In order...
9.
Olsen D, Langkilde A, Schmalbruch H, Vissing J
Eur J Neurol
. 2000 Oct;
7(5):567-71.
PMID: 11054145
The first case of combined centronuclear myopathy and multiple sclerosis is reported. The difficulties of diagnosing multiple sclerosis in patients with muscular disorders associated with the central nervous system involvement...